Article in Japanese
Advances in measles control and measles virus research, and future challenges
Makoto TAKEDA1)
Measles is an acute viral infection characterized by extremely high transmissibility and a substantial case-fatality rate. It induces transient immunosuppression and can lead to the fatal complication subacute sclerosing panencephalitis (SSPE), making it a continuing public health concern. Although scientific understanding of measles virus and its pathogenesis has advanced considerably, no effective therapy for SSPE has been established, and there is still no specific antiviral treatment for acute measles.
In contrast, the antigenic stability of measles virus and the availability of highly effective vaccines render measles theoretically eradicable. In Japan, a two-dose measles-containing vaccine schedule was introduced in 2006 and, together with strengthened surveillance and supplementary immunization programs, led to measles elimination in 2015. However, even after elimination, sporadic cases continue to occur, primarily due to importations from overseas. Declining vaccination coverage and the global epidemiological situation have increased the risk of resurgence.
In recent years, the proportion of adult cases has increased, and the relative frequency of modified measles associated with waning vaccine-induced immunity has also risen, complicating diagnosis and surveillance. Measles thus continues to pose a risk of re-emergence, and further comprehensive measures—integrating clinical practice, epidemiology, and virology—are required to achieve its complete control.
1) Department of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
| Key words | |
|---|---|
| Received | January 1, 1970 |
| Accepted | January 1, 1970 |
38 (3):253─262,2026
- Vol. 38
- Vol. 37
- Vol. 36
- Vol. 35
- Vol. 34
- Vol. 33
- Vol. 32
- Vol. 31
- Vol. 30
- Vol. 29
- Vol. 28
- Vol. 27
- Vol. 26
- Vol. 25
- Vol. 24
- Vol. 23
- Vol. 22
- Vol. 21
- Vol. 20
- Vol. 19
- Vol. 18